You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Bulk Pharmaceutical API Sources for ALLERFED


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for ALLERFED

Vendor Vendor Homepage Vendor Sku API Url
BenchChem ⤷  Start Trial B1236461 ⤷  Start Trial
THE BioTek ⤷  Start Trial bt-1570029 ⤷  Start Trial
J&H Chemical Co.,ltd ⤷  Start Trial JH487488 ⤷  Start Trial
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for: ALLERFED

Last updated: August 2, 2025

Introduction

Allerfed is a brand name associated with antihistaminic medications primarily containing cetirizine dihydrochloride, used to treat allergy symptoms such as hay fever, allergic conjunctivitis, and urticaria. As a pharmaceutical product, the manufacturing quality, safety, and efficacy of Allerfed hinge on consistent sourcing of high-quality Active Pharmaceutical Ingredients (APIs). The procurement of cetirizine API involves navigating a complex supply chain, with multiple global suppliers offering bulk APIs that meet regulatory standards. This article analyzes the landscape of bulk API sources for Allerfed, emphasizing quality assurance, regulatory compliance, and market dynamics.


Understanding Cetirizine API and Market Overview

Cetirizine is a second-generation antihistamine that selectively antagonizes peripheral H1 receptors, offering long-lasting allergy relief with minimal sedation. The global cetirizine API market is competitive, with several manufacturers across India, China, and other regions. The API's quality parameters are strictly controlled, given the stringent requirements of pharmacopeias like USP, EP, and JP, which set impurity profiles, purity levels, and testing protocols.

The reliance on global API manufacturers underscores the importance of verifying sources that can reliably supply quality-certified cetirizine API in bulk quantities. The key factors influencing API sourcing decisions include regulatory compliance, manufacturing capacity, cost, quality standards, and supply chain stability.


Major API Suppliers for Cetirizine

1. Indian API Manufacturers

India remains a dominant supplier of cetirizine API, supported by a robust pharmaceutical manufacturing infrastructure, risk mitigation strategies, and competitive pricing.

  • Dr. Reddy's Laboratories

    Dr. Reddy's offers cetirizine API produced under strict cGMP standards. Their API is compliant with the US Pharmacopeia (USP) and European Pharmacopoeia (EP), making it suitable for export markets. The company has extensive manufacturing facilities in Hyderabad and other industrial zones, with a proven track record of quality and reliability.

  • Aurobindo Pharma

    Aurobindo's API division manufactures cetirizine API with high purity and low impurity profiles, aligned with international standards. Their API manufacturing facilities are FDA-approved, ensuring quality for markets requiring compliance with strict regulatory norms.

  • Sun Pharmaceutical Industries

    Sun Pharma supplies cetirizine API globally, with certifications from USFDA, EUGMP, and other regulatory authorities. They emphasize quality assurance protocols and robust quality control systems, making their APIs suitable for multinational pharmaceutical companies.

  • Hetero Labs

    Hetero offers cetirizine API products with verified purity levels, adhering to the specifications mandated by pharmacopeias. Their manufacturing facilities meet cGMP standards, and they maintain a comprehensive Quality Management System.

2. Chinese API Producers

China also plays a significant role in bulk API supply, driven by scale, cost advantages, and technological development.

  • Qilu Pharmaceutical

    Qilu Pharmaceutical produces cetirizine API with a focus on compliance with USP and EP standards. Their manufacturing plants operate under strict cGMP compliance, and they possess numerous certifications, including ISO 9001 and ISO 14001.

  • North China Pharmaceutical Group Corporation (NCPC)

    NCPC is a major API manufacturer with extensive experience in antihistamines, including cetirizine. Their facilities are approved by Chinese regulatory authorities and have achieved various international certifications, facilitating export to regulated markets.

  • Shenzhen Hepeng Pharmaceutical

    Hepeng supplies cetirizine API targeted at international markets, with WHO-GMP certification and adherence to high-quality manufacturing protocols.

3. Other Notable Global Suppliers

Though India and China dominate the API market, several smaller suppliers and contract manufacturing organizations (CMOs) provide cetirizine API under strict QC standards.

  • Astellas Pharma (Note: Primarily a pharmaceutical company, but involved in manufacturing certain APIs via partnerships)

  • Contract Manufacturers and CMOs: Many pharmaceutical companies outsource API manufacturing to CMOs who comply with cGMP, offering scalable solutions aligned with client-specific quality requirements.


Selecting API Suppliers: Critical Considerations

  • Regulatory Compliance and Certifications

    Ensuring API purity, impurity profile consistency, and adherence to pharmacopeial standards (USP, EP, JP) is paramount. Suppliers should possess relevant certifications such as USFDA, EMA, ISO, and WHO-GMP compliance.

  • Manufacturing Capacity and Lead Times

    Reliable supply demands mass production capabilities, especially for bulk orders. Suppliers with proven track records can mitigate risks of shortages.

  • Quality Control and Testing

    Approved suppliers employ rigorous QC measures, including HPLC purity testing, microbial limits, residual solvents, and heavy metal analysis. Certificates of Analysis (CoA) must be verifiable.

  • Supply Chain Resilience

    Diversifying sources across multiple geographies reduces dependency risks, especially in geopolitical or pandemic-related disruptions.


Regulatory Landscape

APIs used in Allerfed must comply with regulatory standards for safety and efficacy. Regulatory authorities scrutinize API batches for impurities, stability, and manufacturing practices. For international markets, API producers often seek GMP certifications aligned with the target market's standards (FDA, EMA, PMDA, etc.), facilitating smooth approval pathways.


Market Dynamics and Future Outlook

The API sourcing landscape for Allerfed's cetirizine faces evolving challenges and opportunities:

  • Price Pressures: Competitive markets in India and China continue to suppress costs, though quality remains a decisive factor.
  • Regulatory Stringency: An increasing number of regulatory hurdles demand stringent quality control and documentation, favoring established suppliers.
  • Supply Chain Sustainability: The COVID-19 pandemic highlighted vulnerabilities, prompting pharmaceutical companies to diversify their API sourcing to mitigate risks.
  • Biotechnology Integration: Emerging biotechnological manufacturing processes could influence future API production or impurities profiles.

Key Takeaways

  • Indian and Chinese manufacturers dominate the cetirizine API supply chain, offering scalable, cost-efficient, and compliant options.
  • Regulatory compliance, including GMP certification and pharmacopeial adherence, remains the most critical criterion in supplier selection.
  • Diversification of sources reduces supply chain risks and ensures uninterrupted production of Allerfed.
  • Ongoing monitoring of regulatory updates and supplier quality audits is necessary to maintain high standards.
  • Investing in long-term partnerships with verified API suppliers can streamline procurement and ensure product quality.

FAQs

1. What are the primary regulatory standards for cetirizine API suppliers?
Suppliers must comply with GMP standards and have certifications such as USFDA, EMA, or WHO-GMP. They should also meet pharmacopeial specifications like USP, EP, or JP.

2. How can a pharmaceutical company verify API supplier quality claims?
Through independent audits, reviewing Certificates of Analysis, verification of regulatory certifications, and conducting laboratory testing of API samples.

3. What role do CMOs play in API sourcing for Allerfed?
CMOs provide scalable manufacturing solutions, often offering customizable quality profiles, reducing the need for direct oversight of manufacturing facilities.

4. Are there any risks associated with sourcing cetirizine API from China?
Risks include variable compliance standards; however, reputable Chinese suppliers with international certifications mitigate these concerns. Due diligence is essential.

5. How is supply chain resilience maintained amid global disruptions?
By establishing multiple supplier relationships across different countries, maintaining strategic stockpiles, and ensuring transparent communication with suppliers.


References

[1] U.S. Pharmacopeia (USP). Cetirizine API monograph.
[2] European Pharmacopoeia (EP). Cetirizine API specifications.
[3] "Global API Market Report 2022", Pharma Intelligence.
[4] Indian Pharmaceutical Alliance. Report on Indian API exports.
[5] Chinese API Manufacturers Directory, China Pharmaceutical Industry Association.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.